Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Mostrar otras versiones (1)

In patients with chronic myelomonocytic leukemia (CMML), age>65 years is an adverse prognostic factor. Our objective in the current study was to examine risk factors for survival and treatment outcome in 261 ‘young' adults with CMML, as defined by age ⩽65 years. In multivariable analysis, lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404217/
https://www.ncbi.nlm.nih.gov/pubmed/25555161
http://dx.doi.org/10.1038/bcj.2014.90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404217/
https://www.ncbi.nlm.nih.gov/pubmed/25555161
http://dx.doi.org/10.1038/bcj.2014.90

Ejemplares similares